Dow Falls 200 Points After Worse-Than-Feared Inflation Data And Johnson & Johnson Vaccine Concerns
- Date: 13-Apr-2021
- Source: Forbes
- Sector:Financial Markets
- Country:Middle East
Dow Falls 200 Points After Worse-Than-Feared Inflation Data And Johnson & Johnson Vaccine Concerns
Topline
Stocks are mixed near record highs Tuesday as investors largely brush off firmer-than-anticipated inflation data and a potential blow to the nation's inoculation efforts, focusing instead on the Wednesday start of first-quarter earnings season, which will shed light on how corporations have been faring as the economy reopens.
A trader works on the floor of the New York Stock Exchange (NYSE) in New York, U.S., on Wednesday, ... [+] Feb. 26, 2020. U.S. equities swung between gains and losses as investors digested fresh evidence of the widening coronavirus outbreak. Photographer: Michael Nagle/Bloomberg
© 2020 Bloomberg Finance LP
Key Facts
Shortly after the market open, the Dow Jones Industrial Average and the S&P 500—both of which were virtually flat Monday after closing out last week at record highs—fell 181 points, or 0.5%, and 0.1%, respectively, while the tech-heavy Nasdaq jumped 0.4%.
Shares of Johnson & Johnson are slumping more than 2% after officials at the Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) called for a pause on the administration of its Covid-19 vaccine over rare blood clot cases;